At a glance
ClinicalIndex Comparison RecordN/ACompleted· 34,960 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Incidence Probability of Progression to Progressive Fibrosing Interstitial Lung Diseases and Status of Management and Treatments in Patients With Fibrosing Interstitial Lung Diseases Other Than Idiopathic Pulmonary Fibrosis in Japan
In Brief
An observational study for Lung Diseases, Interstitial. Completed, enrolled 34,960 participants across 1 site.
Detailed Summary
The primary objective for this trial is to investigate the incidence probability of progression to Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) in patients with fibrosing ILD other than Idiopathic Pulmonary Fibrosis (IPF) in real-world setting in Japan. The secondary objective is to investigate the characteristics of procedures for management and treatment in patients with fibrosing ILD other than IPF in real-world setting in Japan.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Diseases, Interstitial
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartApr 2023
Primary CompletionMay 2023
First PostedMay 2023
TodayJul 2026
First PostedMay 25, 2023
Enrollment StartApr 20, 2023
Primary CompletionMay 1, 2023
TodayJul 2, 2026
Enrollment to primary: 11 daysPosted 3.1 years ago